NCT00479180View on ClinicalTrials.gov

Safety of Vascugel Treatment After Creation of Arteriovenous Access for Hemodialysis Use

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Hemodialysis Access
Interventions
BIOLOGICAL

Vascugel

One time implant on the day of surgery

BIOLOGICAL

Placebo Comparator

One time implant on the day of surgery

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

Sponsors
All Listed Sponsors
lead

Pervasis Therapeutics, Inc

INDUSTRY